Skip to main content
Premium Trial:

Request an Annual Quote

Abcam Multiplex Cellular and Circulating miRNA Assays

Abcam has launched new multiplex miRNA profiling assays for high-throughput validation of biomarkers. The assays are based on Firefly particle technology.

The Multiplex Cellular and Circulating miRNA Assays allow researchers to profile up to 68 miRNAs in each well of a 96-well plate, read by a standard flow cytometer.

The Cellular assay is optimized for purified miRNA, while the Circulating assay allows profiling from crude samples, including serum and plasma, with no need for RNA purification. 

Abcam offers panels targeting specific diseases as well as customizable panels. 

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.